<p>This week's top stories in cardiology:</p> <ol> <li><a href="http://bit.ly/2Y40M1O">Cognitive decline sped up after CHD</a></li> <li><a href="http://bit.ly/2RqoPp0">Genetic analysis links PCSK9 inhibition and CV mortality</a></li> <li><a href="http://bit.ly/2XoLFD2">Which antidiabetic for elderly patients? It depends on their CV risk</a></li> <li><a href="http://bit.ly/2WQuaax">Pivotal trial shows HFrEF benefits from baroreceptor stimulation</a></li> </ol> <p>You can contact the Cardiocast by emailing us at <a href= "mailto:podcasts@mdedge.com">podcasts@mdedge.com</a> or you can interact with us on Twitter <a href= "http://bit.ly/2TYvkPI">@MDedgeCardio</a></p>

Continue using paclitaxel-eluting PAD devices

MDedge Cardiocast is the weekly podcast from Cardiology News. The information in this podcast is provided for informational and educational purposes only.